• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APYX MEDICAL CORPORATION RENUVION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APYX MEDICAL CORPORATION RENUVION Back to Search Results
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Adhesion(s) (1695)
Event Date 10/06/2021
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2021, a female patient with a history of breast cancer (no chemotherapy or radiation) and previous abdominal surgery underwent liposuction to the lower abdomen followed by subdermal coagulation with renuvion.Three passes utilizing the antegrade-retrograde technique in the superficial and deep treatment planes were performed with generator settings of 80% gas and 2.0 liters of flow.1000cc of tumescent was administered to the patient.During the procedure, 800cc of fluid and fat were removed from the patient, abdominal etching was performed and 800 cc of aspiration was performed.A foam compression garment was worn for 2 months post procedure.The patient did not have lymphatic drainage massage or any relevant techniques performed.Subsequently, the patient presented with abdominal adhesions to the treated area.The surgeon initially planned to have massages performed to the patient in effort to correct the adhesion.However, if massages do not correct the adhesion, he is prepared to release the adhesion if there is no improvement.A peer to peer consultation was held between the surgeon and a member of the apyx medical advisory board.It was noted that this surgeon is relatively "young" in his liposuction career.Techniques and technologies were discussed as well as tumescent anesthesia mixes, settings and endpoints for surgical body contouring and energy treatments.Additionally, major recommendations for best outcomes including possible ways to enhance the cases of tissue adhesions the performing surgeon currently practices was discussed.Guidance on how to treat the adhesions were also provided to the performing surgeon.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RENUVION
Type of Device
RENUVION
Manufacturer (Section D)
APYX MEDICAL CORPORATION
5115 ulmerton road
clearwater FL 33760 4004
Manufacturer Contact
aylin canlar
5115 ulmerton road
clearwater, FL 33760-4004
7273842323
MDR Report Key13238050
MDR Text Key284907483
Report Number3007593903-2022-00002
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 01/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received12/15/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-